Related Experiment Video
Updated: Nov 10, 2025
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
660
Membranous Nephropathy: From Research Bench to Personalized Care
Barbara Moszczuk1,2, Krzysztof Kiryluk3, Leszek Pączek1,4
1Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland.
Journal of Clinical Medicine
|April 3, 2021
Summary
Membranous nephropathy, a kidney disease causing nephrotic syndrome, is rapidly evolving. New diagnostic and treatment approaches, including serological and genomic studies, promise personalized care and may reduce the need for kidney biopsies.
Area of Science:
- Nephrology
- Immunology
- Genomics
- Proteomics
Background:
- Membranous nephropathy is a leading cause of nephrotic syndrome and end-stage kidney disease (ESKD).
- Recent scientific advancements have significantly improved understanding and management of this condition.
- The disease's progression from research to clinical application has been remarkably swift.
Purpose of the Study:
- To review the historical context and traditional management of membranous nephropathy.
- To discuss current, evidence-based treatment recommendations and emerging options.
- To highlight novel diagnostic and prognostic tools, including serological, genomic, and proteomic studies.
Main Methods:
- Literature review of historical and current research on membranous nephropathy.
- Analysis of recent clinical guidelines and treatment strategies.
- Synthesis of findings from serological, immunological, genomic, and proteomic studies.
Main Results:
- Traditional approaches are being updated by recent discoveries.
- Serological markers and genetic profiling show promise for diagnosis and risk stratification.
- Personalized treatment strategies are emerging, potentially reducing reliance on invasive kidney biopsies.
Conclusions:
- Membranous nephropathy management is transitioning towards a personalized approach.
- Non-invasive diagnostic methods are being developed and validated.
- Future research in genomics and proteomics will further refine patient care.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
01:28Chronic Kidney Disease III: Interprofessional Care
179
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
179
01:24Nephrotic Syndrome III : Nursing Management
108
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
108
01:24Nephrotic Syndrome I : Introduction
246
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
246
01:26Nephrotic Syndrome II : Assessment and Medical Management
61
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
61
01:25Chronic Kidney Disease I: Introduction
333
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
333